whitepaper

Application note: Immuno-oncology

Posted: 20 March 2020 | | No comments yet

Identifying next generation targets for cancer immunotherapy.

T cell activation requires two signals: 1) recognition of the antigenic peptide/major histocompatibility complex (MHC) by the T cell receptor (TCR) and 2) antigen-independent co-stimulation induced by interactions between co-signalling molecules expressed on antigen presenting cells (APCs) and their T cell-expressed receptors. In addition, T cell activation can be negatively regulated by co-inhibitory molecules present on APCs, which is crucial for maintaining self-tolerance and regulating the duration and magnitude of immune responses.











To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: Bio-Techne

Related organisations

Send this to a friend